Both in Pharmaceuticals
Nature's Sunshine Products vs Evommune
Over the past year NATR returned −5.9% and EVMN returned −70.3%; their daily moves had a correlation of -0.06.
NATR −5.9% EVMN −70.3%Growth of $1, one year, split-adjusted
| Metric | NATR | EVMN |
|---|---|---|
| Price | $12.92 | $6.01 |
| Market cap | $227.3M | $218.1M |
| Today | +7.04% | +1.18% |
| 1 month | +3.0% | −9.1% |
| 6 months | −50.8% | −74.8% |
| Year to date | −40.1% | −64.9% |
| 1 year | −6.1% | — |
| Revenue growth (YoY) | +1.9% | — |
| Gross margin | 73.7% | — |
| Net margin | 3.0% | — |
| P/E (TTM) | 12.6× | — |
| Price / sales | 0.5× | — |
| Net cash | $82.5M | $200.4M |
| Dividend yield | — | — |
| Volatility (60d) | 24.9% | 87.2% |
| Short % of float | 6.4% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).